Skip to main content
Signal8

Dougan Brady W

SEC insider (Form 3/4/5 filer). CIK 0001878020. Director at Humacyte, Inc. (HUMA). 15 reported Form 4/5 transactions since Sep 2024; latest on Jun 11, 2026. Located in DURHAM, NC.

Companies Dougan Brady W has filed insider reports for

  • Humacyte, Inc. (HUMA): Director
Dougan Brady W profile photo

Dougan Brady W

CIK: 0001878020

Transaction Breakdown

Open Market Buys (P)2 (13.3%)

High conviction signal

Open Market Sales (S)8 (53.3%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)5 (33.3%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Humacyte, Inc. logo
HUMA

Humacyte, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (15 total)

  • Humacyte, Inc. logo
    HUMA

    Humacyte, Inc.

    Jun 11, 2026
    Award

    Stock Options (right to buy)

    Direct
    0 shares-
  • Humacyte, Inc. logo
    HUMA

    Humacyte, Inc.

    Nov 16, 2025
    Award

    Stock Options (right to buy)

    Indirect
    311.1K shares-
  • Humacyte, Inc. logo
    HUMA

    Humacyte, Inc.

    Aug 20, 2025
    Sale
    Indirect
    591.7K shares at avg. $1.58$935K
  • Humacyte, Inc. logo
    HUMA

    Humacyte, Inc.

    Aug 19, 2025
    Sale
    Indirect
    1.1M shares at avg. $1.63$1.8M
  • Humacyte, Inc. logo
    HUMA

    Humacyte, Inc.

    Aug 18, 2025
    Sale
    Indirect
    549.4K shares at avg. $1.83$1.0M
  • Humacyte, Inc. logo
    HUMA

    Humacyte, Inc.

    Jun 12, 2025
    Award

    Stock Options (right to buy)

    Direct
    0 shares-
  • Humacyte, Inc. logo
    HUMA

    Humacyte, Inc.

    Jan 21, 2025
    Award

    Stock Options (right to buy)

    Indirect
    1.1M shares-
  • Humacyte, Inc. logo
    HUMA

    Humacyte, Inc.

    Dec 19, 2024
    Award

    Stock Options (right to buy)

    Indirect
    525 shares-
  • Humacyte, Inc. logo
    HUMA

    Humacyte, Inc.

    Nov 20, 2024
    Sale
    Indirect
    261.4K shares at avg. $4.40$1.2M
  • Humacyte, Inc. logo
    HUMA

    Humacyte, Inc.

    Nov 19, 2024
    Purchase
    Indirect
    1.8K shares at avg. $4.44$8K

1-10 of 15